1 - 20 of about 32
English: Yoshida K, Kawai M, Utsunomiya T, Ishibazawa A, Song YS, Udo MSB, Tasaki Y, Yoshida A., Extracellular matrix gene expression in human trabecular meshwork cells following mechanical fluid flow stimulation , Int J Ophthalmol . , vol.15 (３) (p.388 - 393) , 2022
English: Masayuki Chuma, Aki Nakamoto, Takashi Bando, Takahiro Niimura, Yutaka Kondo, Hirofumi Hamano, Naoto Okada, Mizuho Asada, Yoshito Zamami, Kenshi Takechi, Mitsuhiro Goda, Koji Miyata, Kenta Yagi, Toshihiko Yoshioka, Yuki Izawa-Ishizawa, Hiroaki Yanagawa, Yoshikazu Tasaki, Keisuke Ishizawa, Association between statin use and daptomycin-related musculoskeletal adverse events: A mixed approach combining a meta-analysis and a disproportionality analysis. , Clinical Infectious Disease , 2022 , (IF:9.079)
English: Fukudo M, Tamaki G, Azumi M, Kakizaki H, Matsumoto S, Tasaki Y. , Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma. , Invest New Drugs , vol.39 (2) (p.595 - 604) , 2021
English: Kasamo S, Matsumoto S, Kawasaki Y, Inoue H, Tasaki Y., Changes in prescribing trends and initial pharmacotherapy of children with nocturnal enuresis in Japan: a large-scale medical claims database analysis. , World J Urol , 2021
English: Joe Yamamoto, Tomohiro Omura, Sachiko Kasamo, Shota Yamamoto, Masayoshi Kawata, Atsushi Yonezawa, Yosuke Taruno, Hisako Endo, Hitoshi Aizawa, Nobukatsu Sawamoto, Kazuo Matsubara, Ryosuke Takahashi & Yoshikazu Tasaki, Impact of the catechol-O-methyltransferase Val158Met polymorphism on the pharmacokinetics of L-dopa and its metabolite 3-O-methyldopa in combination with entacapone , Journal of Neural Transmission , vol.128 (p.27 - 36) , 2020
English: Fukudo M, Tamaki G, Azumi M, Kakizaki H, Matsumoto S, Tasaki Y., Absorption of the orally active multikinase inhibitor axitinib as a therapeutic index to guide dose titration in metastatic renal cell carcinoma , Invest New Drugs , vol.39 (2) (p.595 - 604) , 2020
English: Masahide Fukudo, Ryota Ishikawa, Kazuto Mishima, Takashi Ono, Seiji Matsumoto, Yoshikazu Tasaki, Real-World Nivolumab Wastage and Leftover Drug Stability Assessment to Facilitate Drug Vial Optimization for Cost Savings , JCO Oncology Practice , vol.16 (10) (p.e1134 - e1142) , 2020
English: Fujiya M, Ueno N, Kashima S, Tanaka K, Sakatani A, Ando K, Moriichi K, Konishi H, Kamiyama N, Tasaki Y, Omura T, Matsubara K, Taruishi M, Okumura T, Long-chain polyphosphate is a potential agent for inducing mucosal healing of the colon in ulcerative colitis. , Clin Pharmacol Ther , vol.107 (2) (p.452 - 461) , 2020
English: Kashima S, Tanabe H, Tanino M, Kobayashi Y, Murakami Y, Iwama T, Sasaki T, Kunogi T, Takahashi K, Ando K, Ueno N, Moriichi K, Fukudo M, Tasaki Y, Hosokawa M, Mizukami Y, Fujiya M, Okumura T., Lymph Node Metastasis From Gastroesophageal Cancer Successfully Treated by Nivolumab: A Case Report of a Young Patient. , Front Oncol , 2019 , (IF:4.137)
English: Kashiwagi H, Yuhki KI, Imamichi Y, Kojima F, Kumei S, Tasaki Y, Narumiya S, Ushikubi F., Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice. , Thromb Haemost , vol.119 (8) (p.1311 - 1320) , 2019
English: Nakau K, Sugimoto M, Oka H, Kajihama A, Maeda J, Yamagishi H, Kamiyama N, Tasaki Y, Kajino H, Azuma H., Pharmacokinetic Analysis of Drugs for Pediatric Pulmonary Hypertension. , PEDIATRICS INTERNATIONAL , vol.494 (p.16 - 22) , 2016 , (IF:0.868)
English: Yoshikazu Tasaki, Expanding our professional roles improves patient outcomes. , 2015 Forbidden City Pharmacist Forum. , 2015
English: Kunisawa T, Yamagishi A, Suno M, Nakade S, Honda N, Kurosawa A, Sugawara A, Tasaki Y, Iwasaki H., Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease. , Therapeutics Clinical Risk Management , vol.11 (p.107 - 114) , 2015
English: Y. Tasaki, J. Yamamoto, T. Ohkubo, T. Noda, T. Omura, T. Ono, M. Sunoa, T. Sakaguchi, K. Matsubara, Mammalian target of rapamycin (mTOR) mediates neuroprotection by oxicam nonsteroidal anti-inflammatory drugs against MPP+-induced SH-SY5Y cell death. , Society of Neuroscience 2013 , 2013
English: Omura T, Asari M, Yamamoto J, Oka K, Hoshina C, Maseda C, Awaya T, Tasaki Y, Shiono H, Yonezawa A, Masuda S, Matsubara K, Shimizu K., Sodium tauroursodeoxycholate prevents paraquat-induced cell death by suppressing endoplasmic reticulum stress responses in human lung epithelial A549 cells. , Biochem. Biophys. Res. Commun. , vol.432 (p.689 - 694) , 2013 , (IF:2.484)
English: Asari M, Oka K, Omura T, Maseda C, Tasaki Y, Shiono H, Matsubara K, Matsuda M, Shimizu K., Universal fluorescent labeling of amplification products using locked nucleic acids. , Electrophoresis. , vol.34 (3) (p.448 - 455) , 2013 , (IF:3.161)
English: K. Matsubara, M. Asari, M. Suno, T. Awaya, M. Sugawara, T. Omura, J. Yamamoto, C. Maseda, Y. Tasaki, H. Shiono, K Shimizu., Estimation of the duration after methamphetamine injection using a pharmacokinetic model in suspects who caused fatal traffic accidents. , Leg. Med. , vol.14 (4) (p.191 - 196) , 2012
English: Y. Tasaki, J. Yamamoto, T. Omura, T. Sakaguchi, N. Kimura, K. Ohtaki, T. Ono, M. Suno, M. Asari, T. Ohkubo, T. Noda, T. Awaya, K. Shimizu, K. Matsubara., Meloxicam ameliorates motor dysfunction and dopaminergic neurodegeneration by maintaining Akt-signaling in a mouse Parkinson's disease model. , Neurosci. Lett. , vol.521 (1) (p.15 - 19) , 2012 , (IF:2.105)
English: M. Asari, T. Omura, K. Oka, C. Maseda, Y. Tasaki, H. Shiono, K. Matsubara, M. Matsuda, K. Shimizu, Multiplex PCR-based Alu insertion polymorphisms genotyping for identifying individuals of Japanese ethnicity. , Genomics , vol.99 (4) (p.227 - 232) , 2012 , (IF:3.019)
English: T. Omura, M. Asari, J. Yamamoto, N. Kamiyama, K. Oka, C. Hoshina, C. Maseda, T. Awaya, Y. Tasaki, H. Shiono, K. Shimizu, K. Matsubara., HRD1 levels increased by zonisamide prevented cell death and caspase-3 activation caused by endoplasmic reticulum stress in SH-SY5Y cells. , J. Mol. Neurosci. , vol.46 (p.527 - 535) , 2012 , (IF:2.504)
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.